Clinical Trial Results: Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind study evaluating cenobamate as adjunctive therapy for primary generalized tonic-clonic seizures in primary generalized epilepsy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Epilepsy

Drugs mentioned

• Cenobamate (cenobamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Primary Generalized Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2026-07-02